Home|Journals|Articles by Year|Audio Abstracts
 

Case Report

EJMCR. 2022; 6(5): 84-86


Lyme myocarditis with third-degree heart block successfully treated with an early transition from IV ceftriaxone to oral doxycyclinecase report

Adam G. Clements, Mercedes Miller, Brittany Myszka.




Abstract
Cited by 0 Articles

Background: Lyme disease is a common parasitic disease that can cause varied and potentially serious manifestations. The recommendations for treating some manifestations of Lyme are based on low-quality evidence, including for myocarditis. Treatment guidelines vary and are based on very low-quality evidence. IV ceftriaxone is typically recommended until the heart block resolves.
Case Presentation: We report a case of a 31-year-old male admitted to our inpatient service with syncope and bradycardia. He was diagnosed with a third-degree heart block from Lyme disease. He was started on IV ceftriaxone, and his heart block improved. He had an ongoing second-degree atrioventricular block when he requested to be discharged on oral antibiotics rather than continuing IV ceftriaxone. Our patient received four doses of ceftriaxone before discharging from the hospital. He completed 2 weeks of oral doxycycline after discharge. In a follow-up phone call, he reported complete resolution of symptoms.
Conclusion: This case supports the current Infectious Disease Society of America guideline of using intravenous ceftriaxone followed by oral doxycycline after the patient has improved. It also suggests that it may be safe to shorten the period of intravenous antibiotics and hospitalization. Shortening this period would reduce expenses and be more convenient for patients. More research is needed on the duration and preferred agent for treating the complications of Lyme.

Key words: Lyme, heart block, myocarditis, case report, doxycycline.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.